Viewing Study NCT01601093

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:25 AM
Ignite Modification Date: 2026-01-25 @ 3:07 AM
Study NCT ID: NCT01601093
Status: SUSPENDED
Last Update Posted: 2019-07-05
First Post: 2012-04-27
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study on Ceftazidime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection
Sponsor: Xiangbei Welman Pharmaceutical Co., Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Respiratory Tract Infections View
None Urinary Tract Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Respiratory and urinary tract infections View
None Ceftazidime and Sulbactam Sodium for Injection (2:1) View
None Phase Ⅱ View